No significant evidence for protection against cardiovascular outcomes with metformin in heart failure

Metformin did not importantly impact the hazard of cardiovascular outcomes successful patients with bosom nonaccomplishment with reduced ejection fraction and diabetes oregon astatine hazard of diabetes. These were the main findings of the Met-HeFT proceedings and a meta-analysis presented successful a Hot Line league astatine ESC Congress 2026.